Progress on Denosumab Use in Giant Cell Tumor of Bone: Dose and Duration of Therapy

SIMPLE SUMMARY: Giant cell tumor of bone (GCTB) is an aggressive non-cancerous bone tumor. Surgery remains the main treatment for GCTB. Denosumab has been approved for the treatment of advanced or inoperable GCTB. The short-term efficacy and safety of denosumab in inoperable patients have been demon...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Feifan, Liu, Huipan, Deng, Jia, Ma, Wenzhe, Chen, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739142/
https://www.ncbi.nlm.nih.gov/pubmed/36497239
http://dx.doi.org/10.3390/cancers14235758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739142/
https://www.ncbi.nlm.nih.gov/pubmed/36497239
http://dx.doi.org/10.3390/cancers14235758

Ejemplares similares